Aspen Pharmacare Holdings Ltd (APN.JO) stock: key figures, P/E, revenue and dividend

Health Care · South Africa · ISIN ZAE000066692

Price
158.68 ZAR
Market cap
70.37 bn ZAR
P/E (2026)
26.59
P/S (2026)
2.02
Dividend yield
1.46 %
Net margin
7.59 %
Return on equity (ROE)
3.29 %
Return on assets (ROA)
2.44 %

Aspen Pharmacare Holdings Ltd financials

Fiscal year20252026
Revenue43.36 bn ZAR34.87 bn ZAR
Gross profit19.13 bn ZAR14.06 bn ZAR
EBIT1.44 bn ZAR5.40 bn ZAR
Net income-1.08 bn ZAR2.65 bn ZAR
Diluted EPS – continuing operations-2.44 ZAR5.97 ZAR

Full history since 1998, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Aspen Pharmacare Holdings Ltd

Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers sterile products in injectable form primarily administered in hospitals and prescribed and administered by physicians or in a retail pharmacy environment for therapeutic areas, such as anesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Sandostatin, Sustanon, and Xylocaine brands. It also provides over-the-counter topical products through retail pharmacy and fast-moving consumer goods sectors under the EMLA, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for therapeutic areas, including anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Meticorten brands. In addition, the company manufactures active pharmaceutical ingredients; finished dose form products manufactured for third parties; and heparin-based API to third parties. Further, it exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.